Anavex Life Sciences Corp (AVXL)

[Investor2014]

I don't think the sentiment Macfarlane expressed was that there was no significant improvement on the rating scales, but rather that he for the first time is seeing data translated into real improvements to patients.

I am sure if you are someone, like Macfarlane, who has been working with Alzheimer's patients and various drugs for a long time, you know real improvement when you see it!